• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

启动子甲基化与睾丸生殖细胞肿瘤之间的关联:一项荟萃分析和队列研究

Association Between Promoter Methylation and Testicular Germ Cell Tumor: A Meta-analysis and a Cohort Study.

作者信息

Markulin Dora, Vojta Aleksandar, Samaržija Ivana, Gamulin Marija, Bečeheli Ivona, Jukić Irena, Maglov Čedomir, Zoldoš Vlatka, Fučić Aleksandra

机构信息

University of Zagreb, Faculty of Science, Department of Biology, Division of Molecular Biology, Zagreb, Croatia.

University Hospital Centre Zagreb, Department of Oncology, Zagreb, Croatia.

出版信息

Cancer Genomics Proteomics. 2017 Sep-Oct;14(5):363-372. doi: 10.21873/cgp.20046.

DOI:10.21873/cgp.20046
PMID:28871003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5611522/
Abstract

BACKGROUND

The RAS association domain family protein 1a (RASSF1A) is a prominent tumor suppressor gene showing altered promoter methylation in testicular germ cell tumors (TGCT). RASSF1A promoter hypermethylation might represent an early event in TGCT tumorigenesis. We investigated whether the RASSF1A promoter methylation in peripheral blood of TGCT patients can be associated with testicular cancer risk.

MATERIALS AND METHODS

Following a meta-analysis, we performed a cohort study including 32 testicular cancer patients and 32 healthy controls. Promoter methylation of the RASSF1A and O-methylguanine-DNA-methyltransferase (MGMT) genes was analyzed using bisulfite pyrosequencing of DNA from peripheral blood.

RESULTS

Meta-analysis showed an odds ratio (OR) of 7.69 for RASSF1A promoter methylation as a risk factor for TGCT. Cohort study found altered methylation of the RASSF1A promoter in blood of TGCT patients. Methylation was higher in TGCT patients before BEP chemotherapy.

CONCLUSION

The meta-analysis indicates a role of the RASSF1A promoter hypermethylation from peripheral blood in TCGT. We confirmed that finding in our cohort study, which represents the first report of changed RASSF1A promoter methylation in peripheral blood TGCT.

摘要

背景

RAS 关联结构域家族蛋白 1a(RASSF1A)是一种重要的肿瘤抑制基因,在睾丸生殖细胞肿瘤(TGCT)中其启动子甲基化发生改变。RASSF1A 启动子高甲基化可能是 TGCT 肿瘤发生的早期事件。我们研究了 TGCT 患者外周血中 RASSF1A 启动子甲基化是否与睾丸癌风险相关。

材料与方法

在进行荟萃分析之后,我们开展了一项队列研究,纳入 32 例睾丸癌患者和 32 例健康对照。使用外周血 DNA 的亚硫酸氢盐焦磷酸测序分析 RASSF1A 和 O -甲基鸟嘌呤 - DNA -甲基转移酶(MGMT)基因的启动子甲基化情况。

结果

荟萃分析显示,RASSF1A 启动子甲基化作为 TGCT 的危险因素,其优势比(OR)为 7.69。队列研究发现 TGCT 患者血液中 RASSF1A 启动子甲基化发生改变。在接受 BEP 化疗前,TGCT 患者的甲基化水平更高。

结论

荟萃分析表明外周血中 RASSF1A 启动子高甲基化在 TCGT 中发挥作用。我们在队列研究中证实了这一发现,这是外周血 TGCT 中 RASSF1A 启动子甲基化改变的首次报道。

相似文献

1
Association Between Promoter Methylation and Testicular Germ Cell Tumor: A Meta-analysis and a Cohort Study.启动子甲基化与睾丸生殖细胞肿瘤之间的关联:一项荟萃分析和队列研究
Cancer Genomics Proteomics. 2017 Sep-Oct;14(5):363-372. doi: 10.21873/cgp.20046.
2
Aberrant epigenetic inactivation of RASSF1A and MGMT gene and genetic mutations of KRAS, cKIT and BRAF in Indian testicular germ cell tumours.印度睾丸生殖细胞肿瘤中RASSF1A和MGMT基因的异常表观遗传失活以及KRAS、cKIT和BRAF的基因突变
Cancer Genet. 2020 Feb;241:42-50. doi: 10.1016/j.cancergen.2019.10.002. Epub 2019 Oct 13.
3
DNA methylation profiling as a tool for testicular germ cell tumors subtyping.DNA 甲基化分析作为睾丸生殖细胞肿瘤分型的工具。
Epigenomics. 2018 Dec;10(12):1511-1523. doi: 10.2217/epi-2018-0034. Epub 2018 Nov 12.
4
Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.睾丸肿瘤中RASSF1A肿瘤抑制基因频繁发生表观遗传失活以及精原细胞瘤和非精原细胞瘤性睾丸生殖细胞肿瘤的不同甲基化谱。
Oncogene. 2003 Jan 23;22(3):461-6. doi: 10.1038/sj.onc.1206119.
5
Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.MGMT、MLH1 和 RASSF1A 肿瘤抑制基因启动子甲基化与头颈部鳞状细胞癌:药物基因组去甲基化可降低头颈部鳞状细胞癌细胞的增殖。
Oncol Rep. 2012 Apr;27(4):1135-41. doi: 10.3892/or.2012.1624. Epub 2012 Jan 9.
6
Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.涎腺癌中癌症相关基因的启动子甲基化定量分析:与甲基化特异性PCR技术的比较及临床意义
Clin Cancer Res. 2008 May 1;14(9):2664-72. doi: 10.1158/1078-0432.CCR-07-1232.
7
Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.肝癌中 DNA 损伤反应基因的启动子高甲基化。
Cell Biol Int. 2012 May 1;36(5):427-32. doi: 10.1042/CBI20100851.
8
Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients.非CpG启动子甲基化导致的MGMT和RUNX3表达改变及其与食管癌患者不同危险因素的相关性。
Tumour Biol. 2017 May;39(5):1010428317701630. doi: 10.1177/1010428317701630.
9
Pyrosequencing assays to study promoter CpG site methylation of the O6-MGMT, hMLH1, p14ARF, p16INK4a, RASSF1A, and APC1A genes.用于研究O6-甲基鸟嘌呤-DNA甲基转移酶(O6-MGMT)、人错配修复蛋白(hMLH1)、p14ARF、p16INK4a、RASSF1A和APC1A基因启动子CpG位点甲基化的焦磷酸测序分析。
Oncol Rep. 2009 Mar;21(3):721-9.
10
Promoter hypermethylation of RASSF1A, MGMT, and HIC-1 genes in benign and malignant colorectal tumors.良性和恶性结直肠肿瘤中RASSF1A、MGMT和HIC-1基因的启动子高甲基化
Tumour Biol. 2011 Oct;32(5):845-52. doi: 10.1007/s13277-011-0156-7. Epub 2011 Jan 28.

引用本文的文献

1
A multi-analyte liquid biopsy approach for nonseminomatous testicular germ cell tumors: combining cfDNA and N-glycan analysis in blood and seminal plasma.一种用于非精原性睾丸生殖细胞肿瘤的多分析物液体活检方法:结合血液和精浆中的cfDNA和N-聚糖分析
Cancer Cell Int. 2025 Jul 11;25(1):257. doi: 10.1186/s12935-025-03887-8.
2
Recent Advancements in Research on DNA Methylation and Testicular Germ Cell Tumors: Unveiling the Intricate Relationship.DNA甲基化与睾丸生殖细胞肿瘤的研究新进展:揭示复杂关系
Biomedicines. 2024 May 8;12(5):1041. doi: 10.3390/biomedicines12051041.
3
Epigenetic Factors and ncRNAs in Testicular Cancer.表观遗传因子和非编码 RNA 在睾丸癌中的作用。
Int J Mol Sci. 2023 Jul 30;24(15):12194. doi: 10.3390/ijms241512194.
4
Testicular Germ Cell Tumor Tissue Biomarker Analysis: A Comparison of Human Protein Atlas and Individual Testicular Germ Cell Tumor Component Immunohistochemistry.睾丸生殖细胞肿瘤组织生物标志物分析:人类蛋白质图谱与单个睾丸生殖细胞肿瘤成分免疫组织化学的比较。
Cells. 2023 Jul 13;12(14):1841. doi: 10.3390/cells12141841.
5
Epigenetic Regulation of Driver Genes in Testicular Tumorigenesis.表观遗传调控睾丸肿瘤发生中的驱动基因。
Int J Mol Sci. 2023 Feb 19;24(4):4148. doi: 10.3390/ijms24044148.
6
The utility of cfDNA in TGCT patient management: a systematic review.循环游离DNA在睾丸生殖细胞肿瘤患者管理中的应用:一项系统评价
Ther Adv Med Oncol. 2022 May 25;14:17588359221090365. doi: 10.1177/17588359221090365. eCollection 2022.
7
Epigenetics and Testicular Cancer: Bridging the Gap Between Fundamental Biology and Patient Care.表观遗传学与睾丸癌:弥合基础生物学与患者护理之间的差距
Front Cell Dev Biol. 2022 Apr 8;10:861995. doi: 10.3389/fcell.2022.861995. eCollection 2022.
8
GPER and Testicular Germ Cell Cancer.G蛋白偶联雌激素受体与睾丸生殖细胞癌
Front Endocrinol (Lausanne). 2021 Jan 26;11:600404. doi: 10.3389/fendo.2020.600404. eCollection 2020.
9
Epigenetically inactivated RASSF1A as a tumor biomarker.表观遗传失活的 RASSF1A 作为肿瘤标志物。
Bosn J Basic Med Sci. 2021 Aug 1;21(4):386-397. doi: 10.17305/bjbms.2020.5219.
10
Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various Perspectives.睾丸生殖细胞肿瘤中的顺铂耐药性:多视角下的当前挑战
Cancers (Basel). 2020 Jun 17;12(6):1601. doi: 10.3390/cancers12061601.

本文引用的文献

1
MGMT and CALCA promoter methylation are associated with poor prognosis in testicular germ cell tumor patients.O-甲基鸟嘌呤-DNA甲基转移酶(MGMT)和降钙素基因相关肽(CALCA)启动子甲基化与睾丸生殖细胞肿瘤患者的预后不良相关。
Oncotarget. 2016 Aug 10;8(31):50608-50617. doi: 10.18632/oncotarget.11167. eCollection 2017 Aug 1.
2
Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor.鉴定出19个影响睾丸生殖细胞肿瘤易感性的新风险位点及潜在调控机制。
Nat Genet. 2017 Jul;49(7):1133-1140. doi: 10.1038/ng.3896. Epub 2017 Jun 12.
3
The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics.RASSF1A基因启动子甲基化与黑色素瘤易感性及预后的关系:一项荟萃分析和生物信息学研究
PLoS One. 2017 Feb 16;12(2):e0171676. doi: 10.1371/journal.pone.0171676. eCollection 2017.
4
Cancer Death Risk Related to Radiation Exposure from Computed Tomography Scanning Among Testicular Cancer Patients.睾丸癌患者中与计算机断层扫描辐射暴露相关的癌症死亡风险
Anticancer Res. 2017 Feb;37(2):831-834. doi: 10.21873/anticanres.11385.
5
The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel.世界卫生组织2016年睾丸生殖细胞肿瘤分类:国际泌尿病理学会睾丸咨询小组的综述与更新
Histopathology. 2017 Feb;70(3):335-346. doi: 10.1111/his.13102. Epub 2016 Dec 14.
6
Outcome of Resection and Chemotherapy versus Chemotherapy Alone for Retroperitoneal Recurrence of Testicular Cancer Involving the Inferior Vena Cava: A Retrospective Cohort Study of 22 Consecutive Patients.睾丸癌腹膜后复发累及下腔静脉时手术切除联合化疗与单纯化疗的疗效比较:对22例连续患者的回顾性队列研究
Anticancer Res. 2016 Jul;36(7):3483-8.
7
Aberrant Methylation of RASSF1A Closely Associated with HNSCC, a Meta-Analysis.RASSF1A异常甲基化与头颈部鳞状细胞癌密切相关的Meta分析
Sci Rep. 2016 Feb 9;6:20756. doi: 10.1038/srep20756.
8
Testicular germ cell tumours.睾丸生殖细胞肿瘤。
Lancet. 2016 Apr 23;387(10029):1762-74. doi: 10.1016/S0140-6736(15)00991-5. Epub 2015 Dec 3.
9
Epidemiology and Diagnosis of Testis Cancer.睾丸癌的流行病学与诊断
Urol Clin North Am. 2015 Aug;42(3):269-75. doi: 10.1016/j.ucl.2015.04.001. Epub 2015 Jun 11.
10
Cancer Risk in Relatives of Testicular Cancer Patients by Histology Type and Age at Diagnosis: A Joint Study from Five Nordic Countries.基于组织学类型和诊断时年龄的睾丸癌患者亲属的癌症风险:来自五个北欧国家的联合研究。
Eur Urol. 2015 Aug;68(2):283-9. doi: 10.1016/j.eururo.2014.12.031. Epub 2015 Apr 23.